The Size of the APAC Medical Animation Market was valued at USD 24.30 Million in 2022 and is poised to reach USD 63.62 Million by 2027, growing at a CAGR of 21.22% during the forecast period 2022 to 2027.
A form of visual material is medical animation. It is a short film created with 3D computer graphics for instructional purposes on a medical topic, most commonly physiology or surgery. However, it might be any number of medically relevant issues. Medical practitioners use it to utilize 3D medical animations in various ways to improve patient communication.
The emergence of smartphones, tablets, and other platforms has undoubtedly been the most significant trend influencing the APAC medical animation market. Simultaneously, the start-up in the healthcare and life sciences industries has assisted in mainstream medical animation with increased market growth. In addition, technological advancements are proving lucrative growth opportunities for the market players.
Another factor expected to propel market growth is the increased use of medical animation by life science and healthcare technology companies as the number of surgeries increases. Moreover, the rising population with the increase in the prevalence of chronic diseases is expected to increase the market growth. However, medical literacy is still relatively low in non-traditional and disadvantaged areas, demand for medical animation is projected to increase their market steadily. On the other hand, market growth is fueled by rising demand for interactive and three-dimensional medical and pharmaceutical media and expanded operations.
As a result, the number of opportunities in the medical animation sector is growing. For example, medical animation may help or show complex medical processes and pharmaceutical mechanisms of action. In addition, medical animation films can direct audiences, ranging from assisting patients in understanding how a procedure is performed to providing sales demonstrations to medical equipment salespeople.
The market growth is being slowed by the rising prices of medical animation services and procedures. Furthermore, strict regulations for introducing the product and a lack of reimbursement and skilled and trained personnel harm market growth.
This research report on the Asia Pacific Medical Animation Market has been segmented and sub-segmented into the following categories.
By Type:
By Therapeutic Area:
By End User:
By Application:
By Country:
Geographically, the Asia Pacific market is the fastest growing in the medical animation market, and it is expected that it will grow significantly in the coming years. The rise of cancer incidence rate and the growing need for medical animation to illustrate disease mechanisms drive market growth.
Furthermore, large perforation in research and academic institutes when awareness levels rise also, the cosmetic and plastic surgery category is projected to develop rapidly, propelling the market forward. Moreover, the importance of acquiring medical animation for patient education and improving healthcare infrastructure in India, China, Japan, and Australia has increased. In addition, the aging population is increasing, as is the predominant chronic and other disorders.
China's medical animation market is anticipated to witness a significant share in the medical animation market during the forecast period. The Increasing research & development activities, growing awareness, and technological advancements in healthcare sectors are fuel market growth.
KEY MARKET PLAYERS
Top Companies leading the Asia Pacific Medical Animation Market Profiled in the Report are Infuse Medical (U.S.), Hybrid Medical Animation, Inc. (U.S.), Ghost Productions, Inc. (U.S.), Radius Digital Science (U.S.), Nucleus Medical Media, Inc. (U.S.), AXS Studio, Inc. (Canada), Visible Body (U.S.), Elara Systems, Inc. (U.S.), Animated Biomedical Productions (Australia), XVIVO Scientific Animation (U.S.), Scientific Animations, Inc. (U.S.).,
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 3D animation
5.1.2 2D animation
5.1.3 Flash Animation
5.1.4 Real-Time Animation
5.1.5 Y-o-Y Growth Analysis, By Type
5.1.6 Market Attractiveness Analysis, By Type
5.1.7 Market Share Analysis, By Type
5.2 Therapeutic Area
5.2.1 Cardiology
5.2.2 Cosmeceuticals
5.2.3 Oncology
5.2.4 Dental
5.2.5 Other End Users
5.2.6 Y-o-Y Growth Analysis, By Therapeutic Area
5.2.7 Market Attractiveness Analysis, By Therapeutic Area
5.2.8 Market Share Analysis, By Therapeutic Area
5.3 Application
5.3.1 Drug Mechanism of Action
5.3.2 Cellular and Molecular Applications
5.3.3 Patient Education
5.3.4 Surgical Training
5.3.5 Planning
5.3.6 Other Applications
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 End Users
5.4.1 Life Science Companies
5.4.2 Academic Institutes,
5.4.3 Hospitals, Surgical Centres and Clinics
5.4.4 Medical Device Manufacturers
5.4.5 Other End Users
5.4.6 Y-o-Y Growth Analysis, By End Users
5.4.7 Market Attractiveness Analysis, By End Users
5.4.8 Market Share Analysis, By End Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Type
6.1.3.2 By Therapeutic Area
6.1.3.3 By Application
6.1.3.4 By End Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Type
6.1.4.2 By Therapeutic Area
6.1.4.3 By Application
6.1.4.4 By End Users
6.1.5 Market Share Analysis
6.1.5.1 By Type
6.1.5.2 By Therapeutic Area
6.1.5.3 By Application
6.1.5.4 By End Users
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Infuse Medical
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Hybrid Medical Animation, Inc.
8.3 Ghost Productions, Inc.
8.4 Radius Digital Science
8.5 Nucleus Medical Media, Inc.
8.6 AXS Studio, Inc.
8.7 Visible Body
8.8 Elara Systems, Inc.
8.9 Animated Biomedical Productions
8.10 XVIVO Scientific Animation
8.11 Scientific Animations, Inc.
8.12 INVIVO Communications, Inc.
8.13 Random42 Scientific Communication
8.14 Blausen Medical Communications, Inc.
8.15 Trinsic Medical Animation, LLC.
8.16 Viscira
8.17 Understand.com
8.18 Medmovie, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
